Plain-English translation of NCT06248411 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This is the first human trial of , a new experimental cancer medication. Researchers will start with small doses and gradually increase them to find the safest amount that still works against cancer. They will also study how well this treatment works in people with specific types of cancer, such as esophageal cancer or head and neck cancer.
This medication has shown promise in laboratory tests, but doctors need to learn whether it's safe and effective in real patients before it can be considered for wider use. The trial is designed to find the right dose and understand how the treatment affects different types of advanced cancer.
You likely qualify if…
You likely don't qualify if…
You will receive the medication on a regular schedule (the exact frequency and dose will depend on which part of the study you join and what dose level is being tested). Throughout the trial, you'll have regular clinic visits for blood tests, imaging scans, and physical exams to monitor your health and how well the medication is working. You'll also need to provide tumor biopsies at certain points so researchers can study how the treatment affects your cancer at the cellular level.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
Japan